CTRI/2023/03/050509Not yet recruitingUnknown
A prospective pilot study to assess the effect of MUSIc therapy on quality of life of Cancer patients undergoing Chemotherapy in Oncology day care - (MUSICC) - MUSICC
Apollo Proton Cancer Centre0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Patients with a confirmed diagnosis of cancer undergoing chemotherapy in the daycare facility
- •2. Patients aged >18 years
- •3. Patients who are about to start chemotherapy (both curative, palliative intent)
- •4. Physical condition ( minimum performance status of ECOG 3)
- •5. Patients with acceptable English comprehension
Exclusion Criteria
- •1. Patients who have already started chemotherapy
- •2. Lack of English comprehension as the tools of assessment are validated only in English in the digital platform
Investigators
Similar Trials
Not yet recruiting
Unknown
To Investigate whether resveratrol and copper can reduce the amount of virus load in patients with Chronic Hepatitis B and C virus infectioCTRI/2023/05/053055Tata Memorial Hospital
Not yet recruiting
Not Applicable
A prospective pilot study evaluating the effects of a clinically-supervised weight loss intervention programme combined with behavioural change strategy in morbidly obese adults in SingaporePublic Health - Health service researchDiet and Nutrition - ObesityObesityACTRN12612000163808Hanniel Han Rong LIM40
Active, not recruiting
Phase 1
A pilot study to assess the impact of genetic polymorphisms in the ABCB1 and ABCG2 genes on brain and organ penetration of dual Pgp/BCRP substrates in humans.The effect of genetic polymorphisms on drug distribution will be investigated in healthy volunteersEUCTR2012-005796-14-ATMedizinische Universität Wien60
Not yet recruiting
Not Applicable
Estimation of type of hearing loss using a new Forehead knuckle tapping methodCTRI/2021/01/030777Dr Prem Sagar
Active, not recruiting
Phase 1
Study to evaluate the efficacy of OnabotulinumtoxinA in migraineMigraineEUCTR2017-002866-38-ITIRCCS FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE C. MONDINO42